You searched for "theatre"
MedShr-ing is caring
MedShr is an international, award-winning medical education platform that has been created for healthcare professionals (HCPs) to discuss, learn, teach, and (to a lesser degree) network with one another. MedShr was founded in 2014 by Cardiologist Dr Asif Qasim and,...In conversation with Valerie j Lund, BACO International 2018 Master
Professor Lund is ‘Master’ of BACO International 2018. She was made an Honorary Fellow of the American College of Surgeons in October, the first woman in ENT to receive this. ENT & Audiology News Editor, Declan Costello, caught up with...From the editor March/April 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Changes are afoot here at ENT & Audiology News, so loyal readers will notice a few differences for March/April...From the editor May/Jun 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk One of the privileges of editing this magazine is interviewing senior figures within our specialty; so, it was wonderful...
Outcomes of larger glottic cancer volumes treated with radiotherapy
T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...
Antioxidants for bacterial rhinosinusitis
This Turkish laboratory animal-based study looked at the effects of alpha-lipoic acid on inflammation, oxidative status, and tissue integrity in an animal model of experimentally induced acute rhinosinusitis and to compare these effects with antibiotic treatment using cephalosporins. Alpha-lipoic acid...
Metformin, the magical solution!
Both noise-induced hearing loss (NIHL) and vestibular schwannomas (VSs) pose a challenge in terms of management. Metformin was suggested as a potential therapeutic drug for NIHL when the drug-target interaction data was investigated. Additionally, there are studies which demonstrate reduction...
Tumours of the Nose, Sinuses and Nasopharynx
Tumours of the nose, sinuses and nasopharyx is a comprehensive, clear and beautifully illustrated text describing the wide range of benign and malignant tumours of the upper jaw and their management. In such a specialist field, the editors have unparalleled...
Patients with advanced oral cavity carcinoma are not candidates for the ‘organ preservation’ approach
The authors of this study, from the University of Michigan, evaluated the role of induction chemotherapy for patients with stages III and IV resectable oral squamous cell carcinoma. Nineteen patients were initially enrolled in the induction chemotherapy cohort. Patients with...
Lipofilling for scar improvement
Since Coleman et al. in 1991 reported on lipofilling, numerous applications have been reported; these include but are not limited to contour restoration, lip augmentation, and wrinkle therapy. There has also been some one off reported improvements in scars following...
A conservative approach to treat ameloblastoma
Ameloblastoma is an odontogenic tumour that is benign but locally aggressive and is associated with local recurrence. They are rare, accounting for 1% of oral tumours, and occur almost exclusively in the jaws. It is more common in the mandible...
